Biotherapeutics is a multi-billion-dollar industry, with estimates showing that biologics will comprise over half of the 100 top selling drugs and over a third of the total biotherapeutics market in four to five years. However, biotherapeutic development is a challenging journey, starting from lead candidate selection in the lab-scale discovery phase to full biopharmaceutical manufacture. As scientists discover more therapeutics, greater expertise regarding development, clinical testing, regulatory approval, and manufacturing of these new agents is required.
Download this ebook from Cytiva to explore how the right partner can help overcome challenges associated with biotherapeutic development and progress from discovery to the clinic.
